Clinical Trials Arena April 22, 2025
Gain valuable insights into novel therapies, ongoing clinical trials, and future innovations shaping the treatment of Hepatitis B with a new, in-depth report.
Hepatitis B is a highly infectious liver disease caused by the Hepatitis B virus (HBV) and is primarily transmitted through infected blood, bodily fluids, or childbirth. Although many cases are acute and asymptomatic, Hepatitis B can become chronic, posing a serious risk of cirrhosis and liver cancer. It remains a major global health concern, accounting for 65% of the worldwide hepatitis burden, with significant disparities in prevalence and clinical outcomes across regions and ethnicities.
A new report from Novotech, a leading global contract research organization, examines the global clinical trial landscape for Hepatitis B in 2025, offering...
Today's Sponsors
Today's Sponsor